메뉴 건너뛰기




Volumn 22, Issue 11, 2012, Pages 784-795

Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs

(23)  Urban, Thomas J a   Shen, Yufeng h   Stolz, Andrew f   Chalasani, Naga j   Fontana, Robert J k   Rochon, James a   Ge, Dongliang a   Shianna, Kevin V a   Daly, Ann K p   Lucena, M Isabel s   Nelson, Matthew R b   Molokhia, Mariam q   Aithal, Guruprasad P r   Floratos, Aris h   Pe'Er, Itsik i   Serrano, Jose l   Bonkovsky, Herbert c,d   Davern, Timothy J g   Lee, William M m   Navarro, Victor J n   more..


Author keywords

drug induced liver injury; genome wide association study; pharmacogenetics

Indexed keywords

AMOXICILLIN; CLAVULANIC ACID; FLUCLOXACILLIN; STAT4 PROTEIN;

EID: 84867578409     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e3283589a76     Document Type: Article
Times cited : (108)

References (29)
  • 1
    • 0037126649 scopus 로고    scopus 로고
    • Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States
    • Ostapowicz G, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SH, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002; 137:947-954.
    • (2002) Ann Intern Med , vol.137 , pp. 947-954
    • Ostapowicz, G.1    Fontana, R.J.2    Schiodt, F.V.3    Larson, A.4    Davern, T.J.5    Han, S.H.6
  • 2
    • 56149105113 scopus 로고    scopus 로고
    • Using controlled clinical trials to learn more about acute drug-induced liver injury
    • Watkins PB, Seligman PJ, Pears JS, Avigan MI, Senior JR. Using controlled clinical trials to learn more about acute drug-induced liver injury. Hepatology 2008; 48:1680-1689.
    • (2008) Hepatology , vol.48 , pp. 1680-1689
    • Watkins, P.B.1    Seligman, P.J.2    Pears, J.S.3    Avigan, M.I.4    Senior, J.R.5
  • 4
    • 77951553451 scopus 로고    scopus 로고
    • Drug-induced liver injury: Past, present and future
    • Daly AK. Drug-induced liver injury: past, present and future. Pharmacogenomics 2010; 11:607-611.
    • (2010) Pharmacogenomics , vol.11 , pp. 607-611
    • Daly, A.K.1
  • 5
    • 79960941531 scopus 로고    scopus 로고
    • Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry. The dilemma of the relationship to autoimmune hepatitis
    • Lucena MI, Kaplowitz N, Hallal H, Castiella A, Garcia-Bengoechea M, Otazua P, et al. Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry. The dilemma of the relationship to autoimmune hepatitis. J Hepatol 2011.
    • (2011) J Hepatol
    • Lucena, M.I.1    Kaplowitz, N.2    Hallal, H.3    Castiella, A.4    Garcia-Bengoechea, M.5    Otazua, P.6
  • 6
    • 58149347349 scopus 로고    scopus 로고
    • Drug-Induced Liver Injury Network (DILIN) prospective study: Rationale, design and conduct
    • Fontana RJ, Watkins PB, Bonkovsky HL, Chalasani N, Davern T, Serrano J, et al. Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct. Drug Saf 2009; 32:55-68.
    • (2009) Drug Saf , vol.32 , pp. 55-68
    • Fontana, R.J.1    Watkins, P.B.2    Bonkovsky, H.L.3    Chalasani, N.4    Davern, T.5    Serrano, J.6
  • 7
    • 67649859295 scopus 로고    scopus 로고
    • HLAB* 5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
    • Daly AK, Donaldson PT, Bhatnagar P, Shen Y, Pe er I, Floratos A, et al. HLAB* 5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet 2009; 41:816-819.
    • (2009) Nat Genet , vol.41 , pp. 816-819
    • Daly, A.K.1    Donaldson, P.T.2    Bhatnagar, P.3    Shen, Y.4    Pe Er, I.5    Floratos, A.6
  • 8
    • 33745174840 scopus 로고    scopus 로고
    • EUDRAGENE: European collaboration to establish a case-control DNA collection for studying the genetic basis of adverse drug reactions
    • Molokhia M, McKeigue P. EUDRAGENE: European collaboration to establish a case-control DNA collection for studying the genetic basis of adverse drug reactions. Pharmacogenomics 2006; 7:633-638.
    • (2006) Pharmacogenomics , vol.7 , pp. 633-638
    • Molokhia, M.1    McKeigue, P.2
  • 9
    • 18744376412 scopus 로고    scopus 로고
    • Drug-induced liver injury: An analysis of 461 incidences submitted to the Spanish registry over a 10-year period
    • Andrade RJ, Lucena MI, Fernandez MC, Pelaez G, Pachkoria K, Garcia-Ruiz E, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 2005; 129:512-521.
    • (2005) Gastroenterology , vol.129 , pp. 512-521
    • Andrade, R.J.1    Lucena, M.I.2    Fernandez, M.C.3    Pelaez, G.4    Pachkoria, K.5    Garcia-Ruiz, E.6
  • 10
    • 79957523368 scopus 로고    scopus 로고
    • Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class i and II alleles
    • Lucena MI, Molokhia M, Shen Y, Urban TJ, Aithal GP, Andrade RJ, et al. Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. Gastroenterology 2011.
    • (2011) Gastroenterology
    • Lucena, M.I.1    Molokhia, M.2    Shen, Y.3    Urban, T.J.4    Aithal, G.P.5    Andrade, R.J.6
  • 11
    • 0027362542 scopus 로고
    • Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries
    • Danan G, Benichou C. Causality assessment of adverse reactions to drugs-I. a novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993; 46:1323-1330.
    • (1993) J Clin Epidemiol , vol.46 , pp. 1323-1330
    • Danan, G.1    Benichou, C.2
  • 12
    • 50949096560 scopus 로고    scopus 로고
    • The Population Reference Sample, POPRES: A resource for population, disease, and pharmacological genetics research
    • Nelson MR, Bryc K, King KS, Indap A, Boyko AR, Novembre J, et al. The Population Reference Sample, POPRES: a resource for population, disease, and pharmacological genetics research. Am J Hum Genet 2008; 83:347-358.
    • (2008) Am J Hum Genet , vol.83 , pp. 347-358
    • Nelson, M.R.1    Bryc, K.2    King, K.S.3    Indap, A.4    Boyko, A.R.5    Novembre, J.6
  • 13
    • 70349292099 scopus 로고    scopus 로고
    • Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
    • Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009; 461:399-401.
    • (2009) Nature , vol.461 , pp. 399-401
    • Ge, D.1    Fellay, J.2    Thompson, A.J.3    Simon, J.S.4    Shianna, K.V.5    Urban, T.J.6
  • 15
  • 16
    • 41649083448 scopus 로고    scopus 로고
    • WGAViewer: Software for genomic annotation of whole genome association studies
    • Ge D, Zhang K, Need AC, Martin O, Fellay J, Urban TJ, et al. WGAViewer: software for genomic annotation of whole genome association studies. Genome Res 2008; 18:640-643.
    • (2008) Genome Res , vol.18 , pp. 640-643
    • Ge, D.1    Zhang, K.2    Need, A.C.3    Martin, O.4    Fellay, J.5    Urban, T.J.6
  • 17
    • 19944429040 scopus 로고    scopus 로고
    • A single-nucleotide polymorphism tagging set for human drug metabolism and transport
    • Ahmadi KR, Weale ME, Xue ZY, Soranzo N, Yarnall DP, Briley JD, et al. A single-nucleotide polymorphism tagging set for human drug metabolism and transport. Nat Genet 2005; 37:84-89.
    • (2005) Nat Genet , vol.37 , pp. 84-89
    • Ahmadi, K.R.1    Weale, M.E.2    Xue, Z.Y.3    Soranzo, N.4    Yarnall, D.P.5    Briley, J.D.6
  • 18
    • 67249117049 scopus 로고    scopus 로고
    • Potential etiologic and functional implications of genome-wide association loci for human diseases and traits
    • Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 2009; 106:9362-9367.
    • (2009) Proc Natl Acad Sci USA , vol.106 , pp. 9362-9367
    • Hindorff, L.A.1    Sethupathy, P.2    Junkins, H.A.3    Ramos, E.M.4    Mehta, J.P.5    Collins, F.S.6
  • 19
    • 44149127481 scopus 로고    scopus 로고
    • PGA: Power calculator for casecontrol genetic association analyses
    • Menashe I, Rosenberg PS, Chen BE. PGA: power calculator for casecontrol genetic association analyses. BMC Genet 2008; 9:36.
    • (2008) BMC Genet , vol.9 , pp. 36
    • Menashe, I.1    Rosenberg, P.S.2    Chen, B.E.3
  • 20
    • 25444509248 scopus 로고    scopus 로고
    • Power and sample size calculations in the presence of phenotype errors for case/ control genetic association studies
    • Edwards BJ, Haynes C, Levenstien MA, Finch SJ, Gordon D. Power and sample size calculations in the presence of phenotype errors for case/ control genetic association studies. BMC Genet 2005; 6:18.
    • (2005) BMC Genet , vol.6 , pp. 18
    • Edwards, B.J.1    Haynes, C.2    Levenstien, M.A.3    Finch, S.J.4    Gordon, D.5
  • 22
    • 0036140937 scopus 로고    scopus 로고
    • Diclofenac antagonizes peroxisome proliferator-activated receptor-gamma signaling
    • Adamson DJ, Frew D, Tatoud R, Wolf CR, Palmer CN. Diclofenac antagonizes peroxisome proliferator-activated receptor-gamma signaling. Mol Pharmacol 2002; 61:7-12.
    • (2002) Mol Pharmacol , vol.61 , pp. 7-12
    • Adamson, D.J.1    Frew, D.2    Tatoud, R.3    Wolf, C.R.4    Palmer, C.N.5
  • 23
    • 77955270210 scopus 로고    scopus 로고
    • Modulation of inflammatory changes in early stages of colon cancer through activation of PPARgamma by diclofenac
    • Kaur J, Sanyal SN. Modulation of inflammatory changes in early stages of colon cancer through activation of PPARgamma by diclofenac. Eur J Cancer Prev 2010; 19:319-327.
    • (2010) Eur J Cancer Prev , vol.19 , pp. 319-327
    • Kaur, J.1    Sanyal, S.N.2
  • 24
    • 53849149299 scopus 로고    scopus 로고
    • Structure and physiological functions of the human peroxisome proliferator-activated receptor gamma
    • Zieleniak A,Wojcik M,Wozniak LA. Structure and physiological functions of the human peroxisome proliferator-activated receptor gamma. Arch Immunol Ther Exp (Warsz) 2008; 56:331-345.
    • (2008) Arch Immunol Ther Exp (Warsz) , vol.56 , pp. 331-345
    • Zieleniak, A.1    Wojcik, M.2    Wozniak, L.A.3
  • 25
    • 78649824344 scopus 로고    scopus 로고
    • Liver tests are irrelevant when prescribing statins
    • Bader T. Liver tests are irrelevant when prescribing statins. Lancet 2010; 376:1882-1883.
    • (2010) Lancet , vol.376 , pp. 1882-1883
    • Bader, T.1
  • 26
    • 77955082302 scopus 로고    scopus 로고
    • A genomewide study identifies HLA alleles associated with lumiracoxib-related liver injury
    • Singer JB, Lewitzky S, Leroy E, Yang F, Zhao X, Klickstein L, et al. A genomewide study identifies HLA alleles associated with lumiracoxib-related liver injury. Nat Genet 2010; 42:711-714.
    • (2010) Nat Genet , vol.42 , pp. 711-714
    • Singer, J.B.1    Lewitzky, S.2    Leroy, E.3    Yang, F.4    Zhao, X.5    Klickstein, L.6
  • 27
    • 79952173247 scopus 로고    scopus 로고
    • HLADQA1* 02:01 Is a major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancer
    • Spraggs CF, Budde LR, Briley LP, Bing N, Cox CJ, King KS, et al. HLADQA1* 02:01 Is a major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancer. J Clin Oncol 2011; 29:667-673.
    • (2011) J Clin Oncol , vol.29 , pp. 667-673
    • Spraggs, C.F.1    Budde, L.R.2    Briley, L.P.3    Bing, N.4    Cox, C.J.5    King, K.S.6
  • 28
    • 44049102035 scopus 로고    scopus 로고
    • Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis
    • Kindmark A, Jawaid A, Harbron CG, Barratt BJ, Bengtsson OF, Andersson TB, et al. Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis. Pharmacogenomics J 2008; 8:186-195.
    • (2008) Pharmacogenomics J , vol.8 , pp. 186-195
    • Kindmark, A.1    Jawaid, A.2    Harbron, C.G.3    Barratt, B.J.4    Bengtsson, O.F.5    Andersson, T.B.6
  • 29
    • 67949100442 scopus 로고    scopus 로고
    • Co-medications that modulate liver injury and repair influence clinical outcome of acetaminophenassociated liver injury
    • Suzuki A, Yuen N,Walsh J, Papay J, Hunt CM, Diehl AM. Co-medications that modulate liver injury and repair influence clinical outcome of acetaminophenassociated liver injury. Clin Gastroenterol Hepatol 2009; 7:882-888.
    • (2009) Clin Gastroenterol Hepatol , vol.7 , pp. 882-888
    • Suzuki, A.1    Yuen, N.2    Walsh, J.3    Papay, J.4    Hunt, C.M.5    Diehl, A.M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.